MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer

被引：0
|
作者：
Yamasaki, Juntaro [1 ]
Otsuki, Yuji [1 ]
Masuda, Kenta [2 ]
Saya, Hideyuki [3 ]
Nagano, Osamu [1 ]
机构：
[1] Keio Univ, Sch Med, Div Gene Regulat, IAMR, Keio, Japan
[2] Keio Univ, Dept Obstet Gynecol, Sch Med, Keio, Japan
[3] Fujita Hlth Univ, Div Gene Reg, Fujita Canc Ctr, Toyoake, Aichi, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1140
引用
收藏
页码：377 / 377
页数：1
相关论文
共 50 条
  • [31] The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer
    Zhao, Xinchao
    Zheng, Yawen
    Wang, Yufeng
    Zhang, Mingyan
    Dong, Zhilin
    Liu, Yanan
    Sun, Meili
    ONCOTARGETS AND THERAPY, 2024, 17 : 1041 - 1057
  • [32] A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer
    Do, Khanh
    Cao, Liang
    Kang, Zhigang
    Turkbey, Baris
    Lindenberg, Maria L.
    Larkins, Erin
    Holkova, Beata
    Steinberg, Seth M.
    Raffeld, Mark
    Peer, Cody J.
    Figg, William D.
    Eugeni, Michelle
    Jacobs, Paula
    Choyke, Peter
    Wright, John J.
    Doroshow, James H.
    Kummar, Shivaani
    CLINICAL COLORECTAL CANCER, 2015, 14 (03) : 154 - 161
  • [33] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS-mutated lung cancer cells
    Wang, Mei
    Chen, Xu
    Fu, Guang
    Ge, Mingjian
    ONCOLOGY REPORTS, 2022, 48 (06)
  • [34] Management of KRAS-Mutated Non-Small Cell Lung Cancer
    Malhotra, Jyoti
    Nguyen, Danny
    Tan, Tingting
    Semeniuk, George B.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (02) : 67 - 75
  • [35] Active Kras induced metaplasia progression toward gastric neoplasia is suppressed by MEK inhibition during gastric carcinogenesis
    Choi, Eunyoung
    Engevik, Amy C.
    Goldenring, James R.
    CANCER RESEARCH, 2018, 78 (13)
  • [36] MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC).
    Mehdi, Maahum
    Thalji, Samih Z.
    Shreenivas, Aditya V.
    Chakrabarti, Sakti
    Thomas, James P.
    Christians, Kathleen K.
    Evans, Douglas B.
    Hall, William A.
    Erickson, Beth
    Thapa, Bicky
    Ahmed, Gulrayz
    Yazdanpanah, Omid
    Kurzrock, Razelle
    Aldakkak, Mohammed
    Holden, Mary Beth
    Ben George
    Tsai, Susan
    Oxencis, Carolyn
    McFall, Thomas
    Kamgar, Mandana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16260 - E16260
  • [37] Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts
    Reissig, Timm M.
    Ladigan-Badura, Swetlana
    Steinberg, Anja
    Maghnouj, Abdelouahid
    Li, Ting
    Verdoodt, Berlinda
    Liffers, Sven T.
    Pohl, Michael
    Wolters, Heiner
    Teschendorf, Christian
    Viebahn, Richard
    Admard, Jakob
    Casadei, Nicolas
    Tannapfel, Andrea
    Schmiegel, Wolff
    Hahn, Stephan A.
    Vangala, Deepak B.
    MOLECULAR ONCOLOGY, 2023, 17 (11) : 2396 - 2414
  • [38] Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
    Wang, Yuxiang
    Li, Xian
    Liu, Xueling
    Chen, Yi
    Yang, Chunhao
    Tan, Cun
    Wang, Bobo
    Sun, Yiming
    Zhang, Xi
    Gao, Yinglei
    Ding, Jian
    Meng, Linghua
    CANCER BIOLOGY & MEDICINE, 2019, 16 (01) : 66 - +
  • [39] Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses Kras-mutated non-small cell lung cancer
    Wang, Yu-xiang
    Li, Xian
    Liu, Xue-ling
    Wang, Bo-bo
    Chen, Yi
    Yang, Chun-hao
    Ding, Jian
    Meng, Ling-hua
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 44 - 45
  • [40] Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
    Yuxiang Wang
    Xian Li
    Xueling Liu
    Yi Chen
    Chunhao Yang
    Cun Tan
    Bobo Wang
    Yiming Sun
    Xi Zhang
    Yinglei Gao
    Jian Ding
    Linghua Meng
    Cancer Biology & Medicine, 2019, (01) : 66 - 78
12345